Hide This

FREEHER HealthToolkit

HER Health Toolkit

Sign up for EmpowHER updates and you'll receive our
FREE HER Health Toolkit

Breast Cancer

Get Email Updates

Resource Centers

Related Checklists

Breast Cancer Guide

Maryann Gromisch RN Guide

Have a question? We're here to help. Ask the Community.

ASK

Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!

FDA Issues Warning on Nipple Aspirate Test for Breast Cancer

By Lynette Summerill HERWriter
 
Rate This
FDA Issues Warning on Nipple Aspirate Test for Breast Cancer 0 5
FDA warning about nipple aspirate test for breast cancer
Ivelin Radkov/PhotoSpin

Most women would agree that getting a mammogram isn’t much fun. In fact, discomfort is one of the most cited excuses women give for not getting regularly screened for breast cancer, the second most common form of cancer in women.

So when some companies started promoting an easier, more comfortable alternative to mammography some women jumped with glee.

The stand-alone diagnostic test, called a nipple aspirate, has been touted as “literally a PAP test for breast cancer,” for women age 18 and older, according to one company’s literature. The claim was that nipple aspirate tests could detect breast cancer in its earliest and most treatable stages.

The only problem is that the claims are clinically unsubstantiated and could put women at grave risk, according the U.S. Food and Drug Administration (FDA).

The FDA is alerting the public that a nipple aspirate test should not replace mammography, other breast imaging tests, or breast biopsy, nor should the nipple test be used alone to screen for or diagnose breast cancer.

"Our fear is that women will forgo a mammogram and have this test instead. This could result in serious health consequences if breast cancer goes undetected,” said David L. Lerner, M.D., a medical officer at the FDA and a specialist in breast imaging.

A nipple aspirate test uses a breast pump to collect fluid from a woman’s nipples to screen for abnormal and potentially cancerous cells.

In a safety alert, the FDA recommends that women who’ve received a nipple aspirate test as a form of breast cancer screening should also have a mammogram according to screening guidelines or as recommended by their doctor, and should talk to their health care professional about whether additional tests are needed.

“FDA is unaware of any valid scientific data to show that nipple aspirate tests, when used on their own, are an effective screening tool for any medical condition, including the detection of breast cancer or other breast disease,” Lerner said in the written warning.

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Image CAPTCHA
Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.

Improved

1996 Health

Changed

846 Lives

Saved

719 Lives
13 lives impacted in the last 24 hrs Learn More

Take Our Featured Health Poll

Have you been tested for BRCA gene mutation?:
View Results